These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22033867)

  • 1. Psychopharmacology of anxiety disorders.
    Cassano GB; Baldini Rossi N; Pini S
    Dialogues Clin Neurosci; 2002 Sep; 4(3):271-85. PubMed ID: 22033867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    Depress Anxiety; 1999; 9(3):107-16. PubMed ID: 10356648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
    Nicotra CM; Strawn JR
    Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
    Garakani A; Murrough JW; Freire RC; Thom RP; Larkin K; Buono FD; Iosifescu DV
    Front Psychiatry; 2020; 11():595584. PubMed ID: 33424664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine: an update of its use in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis.
    de Vries YA; Roest AM; Burgerhof JGM; de Jonge P
    Depress Anxiety; 2018 Jun; 35(6):515-522. PubMed ID: 29659102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panic Disorder and Agoraphobia in OCD patients: clinical profile and possible treatment implications.
    Torres AR; Ferrão YA; Shavitt RG; Diniz JB; Costa DL; do Rosário MC; Miguel EC; Fontenelle LF
    Compr Psychiatry; 2014 Apr; 55(3):588-97. PubMed ID: 24374170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study.
    Benítez CI; Smith K; Vasile RG; Rende R; Edelen MO; Keller MB
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):5-13. PubMed ID: 18165458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic drugs in the treatment of depressive and anxiety disorders.
    Den Boer JA; Bosker FJ; Slaap BR
    Hum Psychopharmacol; 2000 Jul; 15(5):315-336. PubMed ID: 12404310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent trends in pharmacotherapy for anxiety disorders].
    Tajima O
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):133-6. PubMed ID: 15291242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of duloxetine in the treatment of anxiety disorders.
    De Berardis D; Serroni N; Carano A; Scali M; Valchera A; Campanella D; D'Albenzio A; Di Giuseppe B; Moschetta FS; Salerno RM; Ferro FM
    Neuropsychiatr Dis Treat; 2008 Oct; 4(5):929-35. PubMed ID: 19183783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and disability of comorbid social phobia and obsessive-compulsive disorder in patients with panic disorder and generalized anxiety disorder.
    Camuri G; Oldani L; Dell'Osso B; Benatti B; Lietti L; Palazzo C; Altamura AC
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):248-54. PubMed ID: 25289805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview and clinical presentation of generalized anxiety disorder.
    Rickels K; Rynn M
    Psychiatr Clin North Am; 2001 Mar; 24(1):1-17. PubMed ID: 11225502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of generalized anxiety disorder in obsessive-compulsive disorder patients.
    Sharma P; Rosário MC; Ferrão YA; Albertella L; Miguel EC; Fontenelle LF
    Psychiatry Res; 2021 Jun; 300():113898. PubMed ID: 33812219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and Meta-analysis.
    van Dis EAM; van Veen SC; Hagenaars MA; Batelaan NM; Bockting CLH; van den Heuvel RM; Cuijpers P; Engelhard IM
    JAMA Psychiatry; 2020 Mar; 77(3):265-273. PubMed ID: 31758858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of anxiety disorders: a review.
    Martin P
    Dialogues Clin Neurosci; 2003 Sep; 5(3):281-98. PubMed ID: 22034470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN; Stein MB
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.